Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Tokyo Big Sight

Nov 10, 2019 9:30 AM - Nov 12, 2019 5:40 PM

3-11-1 Ariake, Koto-ku, Tokyo, 135-0063 Japan

16th DIA Japan Annual Meeting 2019

Delivering Rational Medicine for All People in the Globe

[S45] Gene Therapy – Learn from the Cases

Session Chair(s)

Sumimasa  Nagai, MD, PhD

Sumimasa Nagai, MD, PhD

Institute for Advancement of Clinical and Translational Science(iACT)

Kyoto University Hospital, Japan

In recent years, development of gene therapy products in Japan has increased and the first gene therapy product was approved in Japan. Regulatory systems that facilitate practical application of gene therapy (e.g., Cartagena consultation) was newly established. This session will present real world examples from the consultation and review processes in developing such products, from experts in industry and academia. This session will also discuss other issues to consider, such as the difference between these therapeutic products and pharmaceuticals.


Takashi  Kojima, MD, PhD

Practice of Oncolytic Virus - Correspondence to Cartagena Protocol -

Takashi Kojima, MD, PhD

National Cancer Center Hospital East, Japan

Department of Gastrointestinal Oncology

Tetsuya  Ishihama

Development Outline of HGF Plasmid for Conditional Approval and Future Development Plan in Japan

Tetsuya Ishihama

AnGes, Inc., Japan

Director of Clinical Development Department

Takaaki  Yoshida

Points to Consider in the Development of Gene Therapy in Japan

Takaaki Yoshida

Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Reviewer, Office of Cellular and Tissue-based Products

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.